Correlation Between Xbrane Biopharma and XSpray Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xbrane Biopharma and XSpray Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xbrane Biopharma and XSpray Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xbrane Biopharma AB and XSpray Pharma AB, you can compare the effects of market volatilities on Xbrane Biopharma and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xbrane Biopharma with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xbrane Biopharma and XSpray Pharma.

Diversification Opportunities for Xbrane Biopharma and XSpray Pharma

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Xbrane and XSpray is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Xbrane Biopharma AB and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and Xbrane Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xbrane Biopharma AB are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of Xbrane Biopharma i.e., Xbrane Biopharma and XSpray Pharma go up and down completely randomly.

Pair Corralation between Xbrane Biopharma and XSpray Pharma

Assuming the 90 days trading horizon Xbrane Biopharma AB is expected to under-perform the XSpray Pharma. In addition to that, Xbrane Biopharma is 4.3 times more volatile than XSpray Pharma AB. It trades about 0.0 of its total potential returns per unit of risk. XSpray Pharma AB is currently generating about 0.04 per unit of volatility. If you would invest  3,490  in XSpray Pharma AB on August 26, 2024 and sell it today you would earn a total of  635.00  from holding XSpray Pharma AB or generate 18.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Xbrane Biopharma AB  vs.  XSpray Pharma AB

 Performance 
       Timeline  
Xbrane Biopharma 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Xbrane Biopharma AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Xbrane Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
XSpray Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XSpray Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Xbrane Biopharma and XSpray Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xbrane Biopharma and XSpray Pharma

The main advantage of trading using opposite Xbrane Biopharma and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xbrane Biopharma position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.
The idea behind Xbrane Biopharma AB and XSpray Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes